| Genotypes | p-value | |||
|
| AA n (%) | GA n (%) | GG n (%) |
|
| Age category |
|
|
|
|
| <20 | 4 (7.40) | 4 (6.25) | 0 (0.00) | 0.47 |
| 20 à 29 | 27 (50.00) | 31 (48.44) | 24 (42.86) | |
| 30 à 39 | 12 (22.22) | 15 (23.44) | 12 (21.42) | |
| 40 à 49 | 10 (18.52) | 12 (18.75) | 18 (32.14) | |
| 50 and over | 1 (1.85) | 2 (3.12) | 2 (3.57) | |
| Treatment | ||||
| Not specified | 9 (56.25) | 5 (31.25) | 10 (55.55) |
|
| No treatment | 3 (18.75) | 3 (18.75) | 5 (27.77) | <0.001 |
| Tenofovir | 3 (18.75) | 6 (37.50) | 3 (16.67) |
|
| Traditional | 1 (6.25) | 2 (12.50) | 0 (0.00) |
|